First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss

NCT05664100 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

INDUSTRY

Sponsor class

Stopped Business reasons

Conditions

Hearing Loss, Sensorineural

Interventions

DRUG: FX-345
DRUG: Placebo

Sponsor

Frequency Therapeutics